System and method for treating and monitoring post traumatic stress disorder (PTSD)
AssigneeDatChem
InventorsCarolyn Mountford, David Crompton, Nathan Tosh, Rosanna Tremewan
Life of this patent
Estimating the term…
Abstract
A method and system for monitoring therapeutic interventions for treating a patient with PTSD comprises using a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in the brain of the patient before treatment, treating the patient with at least one treatment protocol, after treatment, obtaining post-treatment neural spectroscopic data of the at least one neuromarker chemical in the brain of the patient, and comparing the results of the pre-treatment and post-treatment data to enable a determination of the effectiveness of the treatment.
Claims19
A method of monitoring therapeutic interventions for treating a patient with PTSD by:
- using a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in a brain of the patient before treatment, the at least one neuromarker chemical being at least one of Fuc 7, and PE-Histidine, using a comparator to compare the pre-treatment neural spectroscopic data with neural spectroscopic data of a healthy profile, treating the patient with at least one treatment protocol, after the at least one treatment protocol is performed on the patient, using the scanner to obtain post-treatment neural spectroscopic data of the at least one neuromarker chemical in the brain of the patient, and using the comparator to compare the pre-treatment and post-treatment neural spectroscopic data.
A system for monitoring therapeutic interventions for treating a patient with PTSD, comprising:
- a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in a brain of the patient before any treatment protocol, and after at least one treatment protocol is performed on the patient, to obtain post-treatment neural spectroscopic data of the at least one neuromarker chemical in the brain, and a comparator for comparing the pre-treatment and post-treatment data to enable a determination of whether the treatment protocol was effective at improving PTSD, wherein the neuromarker chemical is at least one of Fuc 7, and PE-Histidine.
A method of monitoring therapeutic interventions for treating a patient with PTSD by:
- using a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in a brain of the patient before at least one treatment protocol, the at least one neuromarker chemical being at least one of Fuc 7, and PE-Histidine, treating the patient with at least one treatment protocol;
- after at least one treatment protocol, using the scanner to obtain post-treatment neural spectroscopic data of the at least one neuromarker chemical in the brain of the patient, and using a comparator to compare the pre-treatment and post-treatment neural spectroscopic data to enable a determination of whether the treatment protocol was effective at treating PTSD.
A method of obtaining a pre-treatment condition of a patient for PTSD, comprising:
- using a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in a brain of the patient, the at least one neuromarker being at least one of Fuc 7, and PE-Histidine, and
- using a comparator to compare the pre-treatment neural spectroscopic data with neural spectroscopic data of a healthy profile to determine a pre-treatment baseline condition of the patient.
A system for obtaining a pre-treatment condition of a patient for PTSD, comprising:
- a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in a brain of the patient before treatment, the at least one neuromarker chemical being at least one of Fuc 7, and PE-Histidine;
- and
- a comparator to compare the pre-treatment neural spectroscopic data with neural spectroscopic data of a healthy profile.
Dependencies are inferred from the claim text.